Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax COIN Option Income Strategy ETF (CONY) vs Eli Lilly And Co (LLY) Price & Performance

YieldMax COIN Option Income Strategy ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

YieldMax COIN Option Income Strategy ETF vs Eli Lilly And Co — how do they compare? YieldMax COIN Option Income Strategy ETF trades at $18.18, while Eli Lilly And Co trades at $1,215.28 (market cap $1.10T). The key difference: Eli Lilly And Co pays a 0.56% dividend while YieldMax COIN Option Income Strategy ETF pays none. Which is the better fit depends on your goals.

CONYLLY
Sector
Income / Options OverlayHealth
52-Week High
$76.50$1.24K
52-Week Low
$17.80$639.43
Market Cap
$1.10T
Enterprise Value
$1.14T
Dividend Yield
0.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax COIN Option Income Strategy ETF

CONY trades at $18.54, up 4.16% today, with a bearish technical signal from moving averages but oversold RSI levels. The ETF shows no fundamental valuation ratios available, and recent news highlights significant shareholder losses despite high distribution yields. Weekly dividends are consistently announced, but underlying performance concerns persist.

Outlook remains cautious due to bearish technicals and negative media sentiment emphasizing value erosion. Risks include reliance on options income strategy and Coinbase volatility. Analyst coverage suggests skepticism, with no bullish catalysts evident near-term.

Eli Lilly And Co

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About YieldMax COIN Option Income Strategy ETF

CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.

Read more on CONY

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY